Font Size:
a
A
A
Keyword [ovarian epithelial carcinoma]
Result: 41 - 59 | Page: 3 of 3
41.
The Expression And Clinical Significance Of TAK1 In Ovarian Epithelial Carcinoma & Its Increasing Of Chemosensitivity To Taxol On SKOV3 And OVCAR3 Cells
42.
The Expressions Of RBM3 In Ovarian Epithelial Carcinoma And The Association With Clinical Pathological Characteristics
43.
Ovarian Cancer After Chemotherapy In Patients With Sugar Metabolic Abnormalities And Clinical Outcomes Of Correlation Research
44.
Expression And Significance Of Osteopontin And CD133 In Ovarian Epithelial Carcinoma
45.
The Diagnostic Value Of Combinationof Serum HMGA2, CA125 And HE4 In Patients With Epithelial Ovarian Cancer
46.
Study Of The Effect And Mechanism Of MiR-650 Targeting DAPK3 On Paclitaxel-Resistance In Ovarian Epithelial Carcinoma
47.
Clinical Observation On Myelosuppresion After Postoperative Chemotherapy Of Epitheilial Ovarian Cancer Treated By Li Chong Sheng Sui Yin
48.
Expression Of IGFBP-3 And GRP78 In Ovarian Epithelial Carcinoma And Its Clinical Significance
49.
Chapter 2 Validation Of Target Gene Zeb1 Of MiR-429 In VIVO
50.
Abnormal Coagulation Function And Its Clinical Significance In Patients With Ovarian Epithelial Carcinoma
51.
Clinical Significance Of Abnormal Expression Of MiR-92a In Serum And Tissue Of Ovarian Epithelial Carcinoma Patients
52.
The Expression And Significance Of ZNF148 In Ovarian Epithelial Carcinoma Were Analyzed By Using The Public Database
53.
The Role Of HE4 Levels Combined With Serum CA125 In The Diagnosis Of Ovarian Epithelial Carcinoma
54.
The Expression Of MYOF In Ovarian Epithelial Carcinoma And Its Clinical Significance
55.
Thapsigargin Inhibits Proliferation,Migration And Invasion Of Ovarian Cancer Cells
56.
The Expression Of SIGLEC-9 In Ovarian Epithelial Carcinoma And Its Clinical Significance
57.
Efficacy And The Prognostic Factors Analysis Of Poly(ADP-ribose) Polymerase Inhibitors In The Treatment Of Recurrent Ovarian Epithelial Carcinoma
58.
CDK4/6 Inhibitor Reverses Acquired Drug Resistance Of PARP Inhibitor In Ovarian Epithelial Carcinoma By Restoring Homologous Recombination Deficiency
59.
Study On The Mechanism Of MiR-429/ZEB1 Axis Regulating The Sensitivity Of Platinum-resistant Ovarian Cancer Cell
<<First
<Prev
Next>
Last>>
Jump to